X-linked Chronic Granulomatous Disease
📧 Sign up to get email alerts when something new happens for X-linked Chronic Granulomatous Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD) [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial for X-linked chronic granulomatous disease sponsored by Genethon has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Gene Therapy for X-linked Chronic Granulomatous Disease [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial for X-linked Chronic Granulomatous Disease sponsored by Genethon has been terminated.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating base editing of hematopoietic stem and progenitor cells to repair mutations causing X-linked chroni…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease [Phase 1, Phase 2]
Recruitment is underway for a Phase 1/2 trial of EN-374 gene therapy in patients with X-Linked Chronic Granulomatous Disease.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Gene Therapy for X-CGD [Phase 1, Phase 2]
A gene therapy trial for X-linked Chronic Granulomatous Disease is in Phase 1/Phase 2, with the current status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.